Sound interesting. The share holder vote is going to be very interesting. There just needs to be more sell from the board with benifit details for the share holders. There is very little to go on at the moment.
I have a little info that a new company may be setup to try to buy CPN10 outright from CBIO. Now the unsubstanciated rumour that it a phama group focused on Lupus and and some other investors.
Lets hope that this hots up the show.
